Skip to main content

Advertisement

Table 3 Discussions at patient-provider visits

From: Patient and primary care provider experience using a family health history collection, risk stratification, and clinical decision support tool: a type 2 hybrid controlled implementation-effectiveness trial

   All participants All non-routine recommendations Disease-specific non-routine recommendations
Breast Cancer∞     
  Risk of breast cancer 48 (22.8%) 29 (23.2%) 18 (32.7%)
  Mammography 125 (59.2%) 68 (54.4%) 33 (60.0%)
  Breast MRI 10 (4.7%) 8 (6.4%) 5 (9.1%)
  Tamoxifen 6 (2.8%) 5 (4%) 4 (7.3%)
Ovarian Cancer∞   19 (9.0%) 13 (10.4%) 6 (50%)
Colon cancer*     
  Risk of colon cancer 113 (30.5%) 50 (29.2%) 39 (34.8%)
  Screening for colon cancer 260 (70.3%) 118 (69.0%) 83 (74.1%)
Thrombosis*   35 (9.5%) 18 (10.5%) 10 (41.7%)
Seeing a specialist*   82 (22.2%) 62 (36.3%) n/a
Lifestyle choices*   192 (51.9%) 83 (48.5%) n/a
  1. ∞Total N = 211 for all participants; 125 for all non-routine recommendations; 55 for breast cancer-specific non-routine recommendations; 12 for ovarian cancer-specific non-routine recommendations.
  2. *Total N = 370 for all participants; 171 for all non-routine recommendations; 112 for colon cancer-specific non-routine recommendations; 24 for thrombosis-specific non-routine recommendations.